Bristol-myers squibb stock
Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Bristol-Myers Squibb Company stock was issued.Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.
Did you know?
Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary.Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Bristol-Myers Squibb Company ... Bristol-Myers Squibb Company (BMY) NYSE: BMY · IEX Real-Time Price · USD. Add to Watchlist 50.10 +0.72 (1.46%) At …Bristol Myers Squibb stock recently dropped to a multiyear low, and the pharmaceutical company’s lead independent director bought shares on the open market for the first time in years.
Bristol-Myers Squibb Co Bristol-Myers Squibb Co BMY Morningstar Rating Unlock Stock XNYS Rating as of Nov 29, 2023 Summary Chart News Price vs …Dec 1, 2023 · Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ... Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Bristol Myers Squibb (BMY) closed the most recent trading day at $65.72, moving -1.19% from the previous trading session. This change was narrower than the S&P 500's daily loss of 1.45%.Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary.
A top big pharma stock. At a hair under eight times forward earnings, the pharmaceutical giant Bristol Myers Squibb ( BMY 0.69%) is Berkshire's third-cheapest stock holding at the moment. Bristol ...Per Share Data Bristol Myers Squibb Co. All values updated annually at fiscal year end. Earnings Per Share +2.95: Sales 21.51: Tangible Book Value-12.37: ... Stock Movers: Gainers, ... ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Bristol-myers squibb stock. Possible cause: Not clear bristol-myers squibb stock.
At Bristol Myers Squibb, the work you do—often in support of emerging therapeutic areas that require new methods of thinking and working—will help people prevail over serious diseases. And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. This isn’t easy work, but it is uniquely ...Nov 28, 2023 · Bristol-Myers Squibb Company is undervalued; there is no denying that at 7X earnings. It is priced for -3% long-term growth, and analysts expect flat growth for the foreseeable future.
According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...It's a new day at Bristol Myers Squibb (), according to a company executive.But BMY stock remains under pressure ahead of a patent cliff threatening $200 billion in pharma sales by 2030. X. Over ...
cell phone insurance providers Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Bristol-Myers Squibb, it has a TSR of 33% for the last 5 years.Bristol-Myers Squibb (NYSE: BMY) stock is falling on Monday after a couple of updates that are weighing on BMY shares today. The first bit of news worth noting is the results from a clinical trial ... clne nasdaqmobile futures trading platform Bristol-Myers Squibb Company Common Stock (BMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. muni bond yields Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bristol-Myers Squibb share forecasts, stock quote and buy / sell signals below. According to present data Bristol-Myers Squibb's BMY shares and potentially its market environment have been in bearish cycle last 12 months (if exists). amzn stock buy or sellbest phone insurance plansnvda stock prediction 2025 Key statistics. Bristol-Myers Squibb Co (BMY:NYQ) set a new 52-week low during today's trading session when it reached 48.25. Over this period, the share price is down -39.13%. Data delayed at least 15 minutes, as of Nov 30 2023 16:26 GMT. Latest Bristol-Myers Squibb Co (BMY:NYQ) share price with interactive charts, historical prices ... top investing firms Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.BMY. Dividend Information. BMY has an annual dividend of $2.28 per share, with a forward yield of 4.58%. The dividend is paid every three months and the last ex-dividend date was Oct 5, 2023. Dividend Yield. 4.58%. … financial planners albany nyge dividendsyears of valuable quarters The average price target for Bristol-Myers Squibb is $60.69. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $72.00 ,the lowest forecast is $50.00. The average price target represents 17.80% Increase from the current price of $51.52.Average Price Target ... Based on 17 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target ...